Experimental stem cell therapy tested for serious lung disease
NCT ID NCT00683722
Summary
This study tested whether multiple infusions of a stem cell product called PROCHYMAL were safe and could help people with moderate to severe COPD. It involved 62 adults who were current or former heavy smokers. Researchers compared the stem cell treatment against a placebo to see if it improved lung function, reduced flare-ups, or helped patients feel better over two years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY DISEASE, CHRONIC OBSTRUCTIVE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
American Health Research
Charlotte, North Carolina, 28207, United States
-
David Geffen School of Medicine at UCLA
Los Angeles, California, 90095, United States
-
Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center
Torrance, California, 90502, United States
-
Spartanburg Medical Research
Spartanburg, South Carolina, 29303, United States
-
Upstate Pharmaceutical Research
Greenville, South Carolina, 29615, United States
-
Vermont Lung Center, University of Vermont
Burlington, Vermont, 05446, United States
Conditions
Explore the condition pages connected to this study.